|
|
Volumn 94, Issue 4 SUPPL., 2002, Pages 1249-1257
|
|
A model-based approach for the optimization of radioimmunotherapy through antibody design and radionuclide selection
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
IODINE 131;
MONOCLONAL ANTIBODY;
RADIOISOTOPE;
RHENIUM 186;
YTTRIUM 90;
CARCINOEMBRYONIC ANTIGEN;
MONOCLONAL ANTIBODY A5B7;
MONOCLONAL ANTIBODY MFE 23;
OXYGEN;
UNCLASSIFIED DRUG;
ANTIBODY AFFINITY;
BONE MARROW TOXICITY;
CELL VIABILITY;
CONFERENCE PAPER;
MATHEMATICAL MODEL;
NONHUMAN;
PRIORITY JOURNAL;
RADIATION DOSE;
RADIATION RESPONSE;
RADIOBIOLOGY;
RADIOIMMUNOTHERAPY;
RADIOSENSITIVITY;
TUMOR VOLUME;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
CELL DEATH;
CELL HYPOXIA;
COLORECTAL CANCER;
COMPARTMENT MODEL;
CONTROLLED STUDY;
DRUG CLEARANCE;
DRUG DESIGN;
DRUG DISTRIBUTION;
DRUG EFFICACY;
DRUG RETENTION;
DRUG SPECIFICITY;
HUMAN;
HUMAN CELL;
IMAGE ANALYSIS;
IN VITRO STUDY;
MATHEMATICAL ANALYSIS;
MEDICAL DECISION MAKING;
MOLECULAR WEIGHT;
MOUSE;
OXYGENATION;
PROCESS OPTIMIZATION;
RADIATION DOSE DISTRIBUTION;
TREATMENT RESPONSE;
TUMOR GROWTH;
|
|
EID: 0037083644
PISSN: 0008543X
EISSN: None
Source Type: Journal
DOI: 10.1002/cncr.10293 Document Type: Conference Paper |
|
Times cited : (11)
|
|
References (30)
|
